Clinical Trial

A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Abdominal Surgery

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The primary objective is to evaluate the analgesic efficacy and safety of IV YZJ-4729 Tartrate Injection in patients with acute postoperative pain following abdominal surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-21.
Status change: Not Yet Recruiting → Active, Not Recruiting 2026-06-26
Trial Details
NCT Number NCT06890533
Lead Sponsor Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Conditions Pain
Enrollment 560 participants
Start Date 2025-05-14
Primary Completion 2026-04-17 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-29